Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "target protein" in the context of PROTACs refers to any intracellular protein that a given PROTAC molecule is designed to bind and induce degradation. The identity of this target varies depending on the specific disease or biological process being addressed, as each PROTAC is engineered with a ligand that selectively binds its intended target protein. This approach enables selective elimination—including previously undruggable targets—by harnessing endogenous cellular machinery rather than relying solely on enzymatic inhibition or occupancy-based antagonism.
PROTAC-mediated degradation via E3 ubiquitin ligase recruitment and proteasomal degradation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Target protein (varies by specific PROTAC).